DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Cezard J, Nouaili N, Talbotec C. et al.
A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factor (remicade) in severe pediatric Crohn’s disease.
J Pediatr Gastroenterol Nutr 2004;
39: 302-303
Access:
We do not assume any responsibility for the contents of the web pages of other providers.